Test report of "subchronic toxicity" and "bone implantation"

Date of issue:



After obtaining 8 biocompatibility test reports in August 2021, the absorbable orthopedic implant products of T-Bright Biotechnology 3D printing obtained the 'subchronic systemic toxicity test' and 'bone implant test' inspection reports issued by the Sichuan Medical Device Biomaterials and Products Inspection Center in December 2022. So far, the products have successfully passed all 10 biocompatibility tests, fully proving that the products have good biological safety.

Test report of

Test report of


T-Bright Biotechnology settled in Suzhou Industrial Park Weili Medical Science and Innovation Park
In order to lay out the 3D pri...
2023 Golden Autumn Youth League Building Activities Successfully Held
On October 27, 2023, the Daiqu...
T-Bright Biotechnology Won Third Prize in the Final of the 6th China Medical Device Competition
The China Medical Device Innov...
Leaders from the National Drug Administration come to our company for research and exchange work
On the morning of July 20, 202...